AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 80 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,682,835 | -25.3% | 163,382 | +19.5% | 0.06% | -28.0% |
Q2 2023 | $2,254,019 | +36.0% | 136,773 | -24.4% | 0.08% | +22.4% |
Q1 2023 | $1,657,960 | +211.9% | 181,000 | +143.8% | 0.07% | +157.7% |
Q4 2022 | $531,630 | -65.9% | 74,250 | -68.2% | 0.03% | -67.1% |
Q4 2020 | $1,561,000 | -24.2% | 233,747 | -42.8% | 0.08% | -43.2% |
Q3 2020 | $2,059,000 | -60.7% | 408,625 | -36.9% | 0.14% | -57.1% |
Q2 2020 | $5,233,000 | +729.3% | 647,708 | +741.2% | 0.32% | +881.8% |
Q4 2017 | $631,000 | -84.7% | 77,000 | -80.3% | 0.03% | -84.1% |
Q3 2017 | $4,114,000 | -44.0% | 391,839 | -41.2% | 0.21% | -47.7% |
Q2 2017 | $7,349,000 | -23.9% | 666,316 | -33.2% | 0.40% | -16.6% |
Q1 2017 | $9,651,000 | – | 997,000 | – | 0.48% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WEALTH EFFECTS LLC | 2,409,289 | $24,815,676 | 12.25% |
Knoll Capital Management, LLC | 600,000 | $6,180,000 | 6.42% |
Vivo Capital, LLC | 4,096,428 | $42,193,208 | 4.62% |
GENDELL JEFFREY L | 5,615,350 | $57,838,105 | 3.29% |
Tri Locum Partners LP | 983,602 | $10,131,101 | 3.24% |
Samsara BioCapital, LLC | 967,527 | $9,965,528 | 3.05% |
MPM BioImpact LLC | 664,224 | $6,841,507 | 1.83% |
COWEN AND COMPANY, LLC | 2,338,302 | $24,084,510 | 1.68% |
RTW INVESTMENTS, LP | 7,136,415 | $73,505,075 | 1.55% |
TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $10,300,000 | 1.45% |